Do genetic variants in HSD11B1 alter local regeneration of cortisol from cortisone?

The relationship between genetic variations in the HSD11B1 gene and the tissue-specific regeneration of active cortisol is strongly supported by metabolic and molecular research.

Mechanistic pathways of cortisol regeneration

• Enzymatic conversion: The HSD11B1 gene encodes 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which operates in vivo primarily as an NADPH-dependent reductase. Its main physiological role is the local, intracellular conversion of inactive cortisone into active cortisol, particularly within key metabolic tissues such as the liver, adipose tissue, and skeletal muscle.
• Transcriptional modulation: Common genetic polymorphisms in HSD11B1, such as rs12086634 and rs846910, do not alter the protein's structural sequence but instead fall within intronic enhancer or promoter regions. These variants define specific haplotypes that directly alter transcription factor binding and gene expression, leading to variable tissue-specific levels of the 11β-HSD1 enzyme.

Clinical and metabolic implications

• Tissue-specific cortisol levels: Altered 11β-HSD1 expression shifts local glucocorticoid action independently of circulating systemic cortisol levels. Enhanced expression and activity of the enzyme result in tissue-specific hypercortisolism, which has been linked to increased risks of metabolic syndrome, obesity, insulin resistance, and polycystic ovary syndrome (PCOS).
• Glucocorticoid clearance: Conversely, variations associated with reduced HSD11B1 expression or activity lead to impaired cortisol regeneration. This results in an altered systemic cortisol-to-cortisone ratio, lower intracellular glucocorticoid signaling, and a compensatory acceleration of hepatic cortisol clearance.

Bottom line

Genetic variations in the HSD11B1 gene, particularly functional non-coding SNPs like rs12086634, directly influence the transcription and activity of the 11β-HSD1 enzyme. This alters the local, tissue-specific regeneration of active cortisol from inactive cortisone, presenting a distinct genetic mechanism for individual variability in glucocorticoid action and metabolic disease susceptibility.